Morphology of the intervertebral disc in high fat combined with streptozotocin-induced type II diabetic rats

doi:10.3969/j.issn.2095-4344.2017.12.014

Abstract

Abstract:

BACKGROUND: Rat models of diabetes mellitus type 2 (T2DM) are usually induced by the combination of high-fat diet and low-dose streptozotocin, but their effects on the intervertebral disc have not yet been reported. Endplate sclerosis is an important factor contributing to intervertebral disc degeneration.
OBJECTIVE: To evaluate whether the rat T2DM model induced by high-fat diet combined with low-dose streptozotocin is suitable for the study of T2DM related intervertebral disc degeneration.
METHODS: Thirty-two 3-month-old female Sprague-Dawley rats were divided into four groups (n=8 per group), including sham, bilateral variectomy, DM, and bilateral variectomy plus DM groups, followed by subjected to bilateral ovariectomy and/or high-fat diet combined with low-dose streptozotocin, respectively. The blood glucose level, body mass and glucose tolerance were determined. The bone mineral density of the lumbar spine was measured after 8-week streptozotocin treatment. The L5-6 segments were removed and cut through midst sagittal plane after decalcification, and then underwent Von Gieson staining and histological degeneration scoring, and the disc height and endplate thickness were measured.
RESULTS AND CONCLUSION: Fasting blood glucose and random blood glucose levels in the DM and bilateral variectomy plus DM groups were significantly higher than those in the other two groups, and the insulin sensitivity in the DM and bilateral variectomy plus DM groups were significantly lower than that in the other groups (P < 0.05). L4-6 vertebral bone mineral density in the bilateral variectomy group was significantly lower than that in the sham group (P < 0.05); L5-6 vertebral bone mineral density in the DM and bilateral variectomy plus DM groups was significantly lower than that in the sham group (P < 0.05). L5-6 vertebral histological scores in the DM and bilateral variectomy plus DM groups were significantly higher than those in the other groups (P < 0.05). Similar with the bilateral variectomy group, there were chondrometaplasia and mucoid degeneration of nucleus pulposus cells in the bilateral variectomy plus DM group, and the histological scores were significantly higher than those in the sham and DM groups (P < 0.05). Compared with the sham group, the intervertebral disc height in the bilateral variectomy and bilateral variectomy plus DM groups was significantly decreased (P < 0.05). While, there was no significant difference in the endplate thickness among groups. These results indicate the combination of high-fat diet and low-dose streptozotocin-induced rat T2DM models possess diabetic characteristics, but the rat intervertebral disc tissues show no significant differences from the normal ones; therefore, this model may be unsuitable for the study on T2DM-related intervertebral disc degeneration.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Diabetes Melitus, Type 2, Osteoporosis, Bone Density, Intervertebral Disk Degeneration, Tissue Engineering

CLC Number:

R318

Liu Guang-yuan, Dai Mu-wei, Tian Fa-ming, Yuan Lei-liang, Geng Lin-dan, Bei Ming-jian, Zhang Liu, Wang Wen-ya. Morphology of the intervertebral disc in high fat combined with streptozotocin-induced type II diabetic rats[J]. Chinese Journal of Tissue Engineering Research, 2017, 21(12): 1883-1888.

Figures/Tables 4

References

[1] Robinson D, Mirovsky Y, Halperin N, et al. Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976). 1998;23(8): 849-855; discussion 856.

[2] Licciardone JC, Kearns CM, Hodge LM, et al. Osteopathic manual treatment in patients with diabetes mellitus and comorbid chronic low back pain: subgroup results from the OSTEOPATHIC Trial. J Am Osteopath Assoc. 2013;113(6): 468-478.

[3] Takahashi S, Suzuki A, Toyoda H, et al. Characteristics of diabetes associated with poor improvements in clinical outcomes after lumbar spine surgery. Spine (Phila Pa 1976). 2013; 38(6): 516-522.

[4] Luoma K, Riihimaki H, Luukkonen R, et al. Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976). 2000;25(4): 487-492.

[5] Park JB, Byun CH, Park EY. Rat Notochordal Cells Undergo Premature Stress-Induced Senescence by High Glucose. Asian Spine J. 2015;9(4): 495-502.

[6] 陈森,徐振华,贾吉光,等.糖尿病大鼠终板微血管改变与髓核细胞凋亡的关系[J]. 武汉大学学报(医学版), 2008, 29(5): 584-586.

[7] Gorth DJ, Shapiro IM, Risbud MV. Discovery of the drivers of inflammation induced chronic low back pain: from bacteria to diabetes. Discov Med. 2015;20(110): 177-184.

[8] He J, Lian C, Fang Y, et al. Effect of CXCL10 receptor antagonist on islet cell apoptosis in a type I diabetes rat model. Int J Clin Exp Pathol. 2015;8(11): 14542-14548.

[9] Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4): 313-320.

[10] Hu H, Xu M, Qi R, et al. Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model. Int J Clin Exp Med. 2015;8(10): 17902-17911.

[11] Gopalakrishnan V, Iyyam Pillai S, Subramanian SP. Synthesis, Spectral Characterization, and Biochemical Evaluation of Antidiabetic Properties of a New Zinc-Diosmin Complex Studied in High Fat Diet Fed-Low Dose Streptozotocin Induced Experimental Type 2 Diabetes in Rats. Biochem Res Int. 2015;2015: 350829.

[12] Tajbakhsh S, Aliakbari K, Hussey DJ, et al. Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes. J Diabetes Res. 2015;2015:153829.

[13] Wang T, Zhang L, Huang C, et al. Relationship between osteopenia and lumbar intervertebral disc degeneration in ovariectomized rats. Calcif Tissue Int. 2004;75(3):205-213.

[14] Hofbauer LC, Brueck CC, Singh SK, et al. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res. 2007;22(9): 1317-1328.

[15] Schwartz AV. Diabetes Mellitus: Does it Affect Bone? Calcif Tissue Int. 2003;73(6): 515-519.

[16] Pan H, Wu N, Yang T, et al. Association between bone mineral density and type 1 diabetes mellitus: a meta-analysis of cross-sectional studies. Diabetes Metab Res Rev. 2014; 30(7): 531-542.

[17] Nakashima A, Nakashima R, Ito T, et al. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus. Diabet Med. 2004;21(9): 1020-1024.

[18] Hou K, Lin C, Wu B, et al. Exogenetic insulin increased bone mineral densityin middle-aged male patients with type 2 diabetes mellitus. Pak J Pharm Sci. 2015;28(6 Suppl): 2227-2230.

[19] Luo Y, Zhang L, Wang WY, et al. The inhibitory effect of salmon calcitonin on intervertebral disc degeneration in an ovariectomized rat model. Eur Spine J. 2015;24(8): 1691-1701.

[20] Zhang W, Shen X, Wan C, et al. Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct. 2012;30(4): 297-302.

[21] Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011; 26(4): 677-680.

[22] Fields AJ, Berg-Johansen B, Metz LN, et al. Alterations in intervertebral disc composition, matrix homeostasis and biomechanical behavior in the UCD-T2DM rat model of type 2 diabetes. J Orthop Res. 2015;33(5): 738-746.